Neogen Shares Outstanding 2010-2025 | NEOG

Neogen shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Neogen Annual Shares Outstanding
(Millions of Shares)
2024 216
2023 189
2022 108
2021 107
2020 106
2019 105
2018 104
2017 102
2016 101
2015 100
2014 99
2013 97
2012 96
2011 95
2010 92
2009 90
Neogen Quarterly Shares Outstanding
(Millions of Shares)
2025-02-28 217
2024-11-30 217
2024-08-31 217
2024-05-31 216
2024-02-29 217
2023-11-30 216
2023-08-31 217
2023-05-31 189
2023-02-28 216
2022-11-30 216
2022-08-31 108
2022-05-31 108
2022-02-28 108
2021-11-30 108
2021-08-31 108
2021-05-31 107
2021-02-28 107
2020-11-30 107
2020-08-31 107
2020-05-31 106
2020-02-29 106
2019-11-30 106
2019-08-31 105
2019-05-31 105
2019-02-28 105
2018-11-30 105
2018-08-31 106
2018-05-31 104
2018-02-28 104
2017-11-30 104
2017-08-31 103
2017-05-31 102
2017-02-28 103
2016-11-30 102
2016-08-31 102
2016-05-31 101
2016-02-29 101
2015-11-30 101
2015-08-31 101
2015-05-31 100
2015-02-28 100
2014-11-30 100
2014-08-31 99
2014-05-31 99
2014-02-28 99
2013-11-30 100
2013-08-31 99
2013-05-31 97
2013-02-28 98
2012-11-30 97
2012-08-31 97
2012-05-31 96
2012-02-29 96
2011-11-30 96
2011-08-31 96
2011-05-31 95
2011-02-28 96
2010-11-30 95
2010-08-31 94
2010-05-31 92
2010-02-28 93
2009-11-30 92
2009-08-31 92
2009-05-31 90
2009-02-28 91
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $1.090B $0.924B
Neogen Corp. develops and markets food and animal safety products. Its Food Safety Division markets culture media and diagnostic test kits to detect foodborne bacteria, natural toxins, food allergens, drug residues, plant diseases and sanitation concerns. Neogen has 2 business segments: Food Safety and Animal Safety. Food Safety: The products in the segment include tests for Mycotoxins, Food allergens, Dairy antibiotics, Foodborne pathogens, Spoilage microorganisms, Sanitation monitoring, Dehydrated culture media and Seafood contaminants. Animal Safety: The division is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, diagnostic products, rodenticides, cleaners, disinfectants, insecticides and genomics testing services for the worldwide animal safety market. These products are marketed via national & international distributors and farm supply retail chains in the U.S. and Canada. It acquired Delta Genomics Centre in Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $218.750B 25.66
Boston Scientific (BSX) United States $152.620B 38.21
Stryker (SYK) United States $150.824B 31.54
EssilorLuxottica (ESLOY) France $131.932B 0.00
Medtronic (MDT) Ireland $117.545B 16.66
Lonza Group Ag (LZAGY) Switzerland $49.596B 0.00
Haleon (HLN) United Kingdom $43.351B 24.74
ResMed (RMD) United States $39.208B 29.45
GE HealthCare Technologies (GEHC) United States $35.024B 16.63
Agilent Technologies (A) United States $33.005B 21.52
Koninklijke Philips (PHG) Netherlands $24.092B 16.91
Terumo (TRUMY) Japan $23.645B 30.71
Insulet (PODD) United States $20.097B 78.89
Zimmer Biomet Holdings (ZBH) United States $19.096B 12.26
Baxter (BAX) United States $14.117B 10.54
Smith & Nephew SNATS (SNN) United Kingdom $13.547B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.680B 23.25
Lantheus Holdings (LNTH) United States $5.005B 12.62
Perrigo (PRGO) Ireland $3.788B 9.60
Prestige Consumer Healthcare (PBH) United States $3.776B 16.87
Haemonetics (HAE) United States $3.565B 16.24
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.397B 28.23
ICU Medical (ICUI) United States $3.107B 22.91
LeMaitre Vascular (LMAT) United States $1.816B 40.60
QuidelOrtho (QDEL) United States $1.727B 11.88
AtriCure (ATRC) United States $1.454B 0.00
Acuren (TIC) United States $1.435B 0.00
AdaptHealth (AHCO) United States $1.279B 12.99
Green Thumb Industries (GTBIF) United States $1.243B 27.96
Phibro Animal Health (PAHC) United States $1.185B 15.15
BioLife Solutions (BLFS) United States $1.024B 0.00
InMode (INMD) Israel $0.911B 9.18
Kestra Medical Technologies (KMTS) United States $0.874B 0.00
Tilray Brands (TLRY) Canada $0.791B 0.00
Curaleaf Holdings (CURLF) Canada $0.784B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.644B 0.00
Owens & Minor (OMI) United States $0.626B 5.19
Evolus (EOLS) United States $0.617B 0.00
CeriBell (CBLL) United States $0.561B 0.00
Valneva SE (VALN) France $0.530B 0.00
ZimVie (ZIMV) United States $0.522B 23.71
Surmodics (SRDX) United States $0.456B 0.00
SNDL (SNDL) Canada $0.431B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.315B 0.00
VAREX IMAGING (VREX) United States $0.312B 11.48
Cresco Labs (CRLBF) United States $0.307B 0.00
Sanuwave Health (SNWV) United States $0.303B 0.00
Capricor Therapeutics (CAPR) United States $0.298B 0.00
Aurora Cannabis (ACB) Canada $0.284B 84.17
Quanterix (QTRX) United States $0.275B 0.00
Cerus (CERS) United States $0.273B 0.00
OraSure Technologies (OSUR) United States $0.258B 0.00
Viemed Healthcare (VMD) United States $0.257B 21.67
Canopy Growth (CGC) Canada $0.256B 0.00
Sanara MedTech (SMTI) United States $0.234B 0.00
Brainsway (BWAY) Israel $0.229B 60.50
Biote (BTMD) United States $0.225B 6.34
Verano Holdings (VRNOF) United States $0.220B 0.00
Omeros (OMER) United States $0.219B 0.00
Organigram Global (OGI) Canada $0.208B 0.00
High Tide (HITI) Canada $0.195B 0.00
Utah Medical Products (UTMD) United States $0.183B 14.93
TriSalus Life Sciences (TLSI) United States $0.170B 0.00
Vireo Growth (VREOF) United States $0.153B 0.00
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.124B 15.32
TerrAscend (TSNDF) Canada $0.112B 0.00
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.099B 12.77
MacroGenics (MGNX) United States $0.097B 0.00
Quipt Home Medical (QIPT) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Jushi Holdings (JUSHF) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Veru (VERU) United States $0.084B 0.00
Safety Shot (SHOT) United States $0.081B 0.00
Zynex (ZYXI) United States $0.074B 0.00
InterCure (INCR) Israel $0.072B 0.00
Agape ATP (ATPC) $0.068B 0.00
Cytosorbents (CTSO) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.062B 0.00
United-Guardian (UG) United States $0.044B 15.11
Rockwell Medical (RMTI) United States $0.039B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 50.14
Allurion Technologies (ALUR) United States $0.024B 0.00
INLIF (INLF) $0.015B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00